Asset One Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Asset One Wealth Management's BMY Position: Q2 2026 in Review
Asset One Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, buying an estimated $121K and bringing the position to 76,968 shares worth $4.52M. The position accounts for 0.48% of the portfolio, ranked #60.
Asset One Wealth Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Asset One Wealth Management held 76,968 shares of Bristol-Myers Squibb worth $4.52M as of Q2 2026.
- Asset One Wealth Management bought 2,102 Bristol-Myers Squibb shares in Q2 2026, an estimated $121K.
- Bristol-Myers Squibb made up 0.48% of Asset One Wealth Management's portfolio in Q2 2026, its #60 holding.
- Asset One Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Asset One Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.